Revision history of "Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials" (Q4335635)
From MaRDI portal
Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.
